2026 Medication-Assisted Substance Use Treatment Grant Program
Funds Pennsylvania counties to implement or expand jail-based Medication-Assisted Treatment programs for opioid and alcohol use disorders, supporting evidence-based care and continuity for incarcerated individuals.
Funder: Pennsylvania Commission on Crime and Delinquency
Due Dates: January 13, 2026 | April 16, 2026 | July 14, 2026
Funding Amounts: Up to $250,000 per county for a 24-month project; total program funding approx. $7.7 million.
Summary: Supports Pennsylvania counties in establishing or expanding jail-based Medication-Assisted Treatment (MAT) programs for offenders with opioid or alcohol use disorders.
Key Information: Only counties with a county jail are eligible; applications must be submitted via the PCCD Egrants system.
Description
This program, administered by the Pennsylvania Commission on Crime and Delinquency (PCCD), funds Pennsylvania counties to implement or expand jail-based Medication-Assisted Treatment (MAT) programs for individuals with opioid or alcohol use disorders. The initiative aims to improve treatment during incarceration and ensure continuity of care upon reentry into the community, using FDA-approved medications (buprenorphine, methadone, naltrexone/Vivitrol) in combination with comprehensive substance use disorder treatment. Counties must collaborate with local and state partners, implement evidence-based practices, maintain robust reporting, and ensure effective project outcomes.
